Lyndra Therapeutics, Inc. of WATERTOWN, MA, a company, filed a Form D exempt-offering notice with the SEC on 2016-07-13. The offering totals $5.9M, of which $5.9M was reported sold. Industry: Biotechnology.
Showing 25 of 35 people.
| Name | Role | Location |
|---|---|---|
| Edmund M Harrigan | Director | Cambrige, MA |
| Robert M Langer | Director | Cambridge, MA |
| Catherine M Reynolds | Director | Cambridge, MA |
| Carlo Giovanni M Traverso | Director | Cambridge, MA |
| Andrew M Bellinger | Executive Officer | Cambridge, MA |
| Amy Schulman | Director | Cambridge, MA |
| Robert Langer | Director | Pittsburgh, PA |
| Catherine Reynolds | Director | Durham, NC |
| Zafi S Avnur | Director | Watertown, MA |
| Ashish S Singh | Director | Watertown, MA |
| Jessica Ballinger | Director | Watertown, MA |
| Jessica Ballinger | Executive Officer | Watertown, MA |
| Doug S Dachille | Director | Watertown, MA |
| Patricia S Hurter | Director | Watertown, MA |
| Catherine S Reynolds | Director | Watertown, MA |
| Helene S Madonick | Director | Watertown, MA |
| Carlo Giovanni Traverso | Director | Watertown, MA |
| Jillian Moo-Young | Director | Watertown, MA |
| Doug Giovanni Dachille | Director | Watertown, MA |
| Jessica Giovanni Ballinger | Executive Officer | Watertown, MA |
| Patricia Hurter | Director | Watertown, MA |
| Patricia Hurter | Executive Officer | Watertown, MA |
| Zafi Avnur | Director | Watertown, MA |
| Catherine Giovanni Reynolds | Director | Watertown, MA |
| Ashish Giovanni Singh | Director | Watertown, MA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2023-12-29 | D | $206.1M | $122.7M |
| 2023-06-07 | D | $179.3M | $20.4M |
| 2021-06-23 | D | $65.0M | $60.5M |
| 2019-01-28 | D | $60.9M | $55.2M |
| 2017-04-19 | D/A | $23.1M | $23.1M |
| 2017-03-07 | D/A | $20.1M | $20.1M |
| 2017-02-10 | D/A | $17.1M | $17.1M |